Skip to content

DR. BORKELMANS

Active Private limited companyfounded 2012active for 14 yearsPutstraat 49, 3630 MaasmechelenKBO/BCE: BE 0844.079.548

Timeline

29 events since 2012

The 2026 accounts are due by 31-07-2027.

2026
Annual accounts 2025 filed NBBmicro format · 21 days before the deadline
2025
Liquidity more than doubled current ratio 42.17 The current ratio rises from 14.72 to 42.17. Short-term debt falls from €10,093 to €4,884.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0844079548
Annual accounts 2024 filed PDFmicro format · 11 days before the deadline
2024
Annual accounts 2023 filed PDFmicro format · 16 days before the deadline
2023
Liquidity more than 14 times current ratio 15.50 The current ratio rises from 1.04 to 15.50. Short-term debt falls from €193,475 to €6,925.
Annual accounts 2022 filed PDFmicro format · 23 days late
2022
Annual accounts 2021 filed PDFmicro format · 13 days before the deadline
2021
Annual accounts 2020 filed PDFmicro format · 48 days late
resigns as manager reappointed as director · Director discharge: · General meeting of 10-06-20217 points ▸
  • Director resignation, (manager)
  • Director reappointment,
  • Director discharge,
  • Registered office clause, Putstraat 49
  • Power of attorney,
  • General meeting, 10-06-2021
  • 100 shares
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

2020
Annual accounts 2019 filed PDFmicro format · 76 days late
2019
Annual accounts 2018 filed PDFmicro format · 42 days late
2018
Weakest financial year net €20,417 ▼26.1% The net result drops to €20,417, the lowest from 2012 to 2025. It recovers the following year.
Liquidity more than doubled current ratio 4.32 The current ratio rises from 1.88 to 4.32. Short-term debt falls from €58,222 to €20,799.
Annual accounts 2017 filed PDFmicro format · 48 days late
Demerger: Dr. Borkelmans splits off to Dr. Groffils, praktijk ThomasboslaanFounding capital of €339,118.76 · The capital rose from €18,600 to €536,867.49 · The capital fell from €536,867.49 to €197,748.73 · appointed as manager · General meeting of 15-12-201715 points ▸
  • General meeting, 15-12-2017
  • Capital increase, €518,267.49
  • Auditor report, 20-11-2017
  • holds 50 shares
  • holds 50 shares
  • Accounting effect, 01-01-2017
  • Capital decrease, €339,118.76
  • Founding capital, €339,118.76, 100 shares
  • Founder,
  • Founder,
  • Capital, €339,118.76, 100 shares
  • 100 shares
  • Director appointment, (manager (not named in the articles))
  • Capital, €197,748.73, 100 shares
  • Power of attorney,
  • The deed holds 11 more points.

Open the deed in the Belgian Official Gazette

2017
Demerger proposal: Dr. Borkelmans splits off to Dr. Groffils, praktijk Thomasboslaan afgekort Dr. Groffils appointed as company auditor · Partner: (geneesheer vennoot) · Partner: · Board meeting of 01-01-20178 points ▸
  • Board meeting, 01-01-2017
  • Partner, (geneesheer vennoot)
  • Partner,
  • Capital, €18,600, 100 shares
  • Registered office clause, Putstraat 49, 3630 Maasmechelen
  • Share issue, €100
  • Accounting effect, 01-01-2017
  • Auditor appointment, (company auditor)
  • The deed holds 10 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2016 filed PDFmicro format · 4 days late
2016
Equity above €500,000 equity €536,867 ▲31.1% With a profit in every financial year since 2012, equity grows to €536,867.
Annual accounts 2015 filed PDFabbreviated format · 78 days late
2015
Liquidity more than doubled current ratio 7.10 The current ratio rises from 2.83 to 7.10. Short-term debt falls from €98,697 to €42,018.
Annual accounts 2014 filed PDFabbreviated format · 60 days late
2014
Highest result from 2012 to 2025 net €132,632 ▲21.1% The operating result of €222,115 and the net result of €132,632 are both a record.
Equity above €200,000 equity €302,730 ▲78% With a profit in every financial year since 2012, equity grows to €302,730.
Annual accounts 2013 filed PDFabbreviated format · 122 days late
Director in office: (manager) PDF
2013
Equity above €150,000 equity €170,098 ▲181% With a profit in every financial year since 2012, equity grows to €170,098.
Annual accounts 2012 filed PDFabbreviated format · 31 days late
2012
IncorporationFounding capital of €18,600, 100 shares, €12,400 paid up · Founded by (partner and founder) · appointed as manager · published on 13-03-20123 points ▸
  • Founder, (partner and founder)
  • Founding capital, €18,600, 100 shares
  • Director appointment, (manager)
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

DR. BORKELMANS was incorporated on 28 February 2012 by one private individual, with a starting capital of €18,600.12 In 2018 the capital was increased by €518,267 to €536,867.3 is manager of the company, appointed by deed of 13-03-2012.2 Total assets went from €272,567 in 2018 to €262,155 in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 13-03-2012
  3. 3Belgian Official Gazette, 15-01-2018
  4. 4National Bank, annual accounts 2018 and 2025

Next steps